ClinicalTrials.Veeva

Menu
V

Velocity Clinical Research | Waco, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

RO7204239
Icotrokinra
RO7795081
BMF-219
Dotinurad
Tirzepatide
Xanthine
RGT001-075
JNJ-77242113

Parent organization

This site is a part of Velocity Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 6 total trials

A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants

The primary objective of this trial is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 in participants with gout w...

Enrolling
Gout
Drug: Dotinurad
Other: Placebo

The main aim of the study is to assess the effect of RO7204239 in combination with tirzepatide, compared to placebo in combination with tirzepatide,...

Active, not recruiting
Overweight
Obesity
Drug: Tirzepatide
Drug: RO7204239 Matching Placebo

This multicenter, randomized, double-blind, placebo- and open-label active comparator-controlled, parallel-group, dose-range-finding, Phase II study...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Semaglutide
Drug: Placebo

The purpose of this study is to evaluate the efficacy of icotrokinra (JNJ-77242113) compared to placebo in biologic-experienced and biologic-naive pa...

Enrolling
Arthritis, Psoriatic
Drug: Placebo
Drug: Icotrokinra

Trial sponsors

Roche logo
B
Janssen (J&J Innovative Medicine) logo
R
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems